KIT and gastrointestinal stromal tumor: It is well known that some c-KIT mutations could represent a limitation in the use of TKIs, i.e. mutations of c-KIT exon 17 such as D816V and occurring in ~80% of adult mastocytosis, and some mutations of c-KIT exon 9 in GIST [9, 46].